We are live on ! Find out more
BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

7 hedge funds and large institutions have $13.8M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 229 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% less funds holding in top 10

Funds holding in top 10: 32 → 1 (-31)

97% less funds holding

Funds holding: 240 → 7 (-233)

99% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 229

100% less capital invested

Capital invested by funds: $8.78B → $13.8M (-$8.77B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
7
Holders Change
-233
Holders Change %
-97.08%
% of All Funds
0.11%
Holding in Top 10
1
Holding in Top 10 Change
-31
Holding in Top 10 Change %
-96.88%
% of All Funds
0.02%
New
2
Increased
–
Reduced
4
Closed
229
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$9.87K
2
MSCM
McElhenny Sheffield Capital Management
Texas
+$4.71K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$748M
2
UOC
UBS O'Connor
Illinois
-$572M
3
HI
HBK Investments
Texas
-$537M
4
Stifel Financial
Stifel Financial
Missouri
-$464M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$349M
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
151
Zurich Cantonal Bank
Switzerland
– -$1.16M -7,673 Closed
Public Employees Retirement Association of Colorado
152
Public Employees Retirement Association of Colorado
Colorado
– -$1.1M -7,268 Closed
Victory Capital Management
153
Victory Capital Management
Texas
– -$1.08M -7,150 Closed
VPIM
154
Vanguard Personalized Indexing Management
California
– -$945K -6,248 Closed
Vontobel Holding
155
Vontobel Holding
Switzerland
– -$907K -6,000 Closed
TRCT
156
Tower Research Capital (TRC)
New York
– -$896K -5,928 Closed
Wells Fargo
157
Wells Fargo
California
– -$838K -5,544 Closed
Commonwealth Equity Services
158
Commonwealth Equity Services
Massachusetts
– -$833K -5,512 Closed
Bank of Nova Scotia
159
Bank of Nova Scotia
Ontario, Canada
– -$811K -5,364 Closed
AIP
160
Ameritas Investment Partners
Nebraska
– -$737K -4,881 Closed
Prudential Financial
161
Prudential Financial
New Jersey
– -$684K -4,511 Closed
Los Angeles Capital Management
162
Los Angeles Capital Management
California
– -$642K -4,250 Closed
BA
163
Bridgewater Associates
Connecticut
– -$640K -4,232 Closed
AF
164
Advisornet Financial
Minnesota
– -$621K -4,108 Closed
Mackenzie Financial
165
Mackenzie Financial
Ontario, Canada
– -$614K -4,060 Closed
SACTSONJ
166
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
– -$605K -4,000 Closed
MLICM
167
Metropolitan Life Insurance Company (MetLife)
New York
– -$573K -3,791 Closed
CSS
168
Cubist Systematic Strategies
Connecticut
– -$565K -3,740 Closed
EGM
169
Engineers Gate Manager
New York
– -$538K -3,556 Closed
X
170
Xponance
Pennsylvania
– -$535K -3,542 Closed
Janney Montgomery Scott
171
Janney Montgomery Scott
Pennsylvania
– -$522K -3,454 Closed
FWA
172
FSC Wealth Advisors
New York
– -$499K -3,300 Closed
Envestnet Asset Management
173
Envestnet Asset Management
Illinois
– -$480K -3,174 Closed
CCM
174
CTC Capital Management
Illinois
– -$469K -3,100 Closed
CAN
175
Cetera Advisor Networks
California
– -$456K -3,018 Closed
5 6
7
8 9

BHVN Hedge Fund Activity: Q4 2022 in Review

7 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Biohaven Pharmaceutical Holding Company Ltd. (BHVN) for Q4 2022, worth a combined $13.8M — down 100% from $8.78B a quarter earlier.

Sellers outnumbered buyers: 229 funds closed out of BHVN and 2 opened new positions — a net loss of 227 holders — while 4 trimmed existing stakes and 0 added.

The largest buyer was Blue Trust Inc, opening a new position worth an estimated $9.87K. The largest seller was BlackRock, exiting entirely with an estimated $748M sold.

  • 7 institutional investors held Biohaven Pharmaceutical Holding Company Ltd. (BHVN) as of Q4 2022, down from 240 in Q3 2022.
  • Funds reported $13.8M of Biohaven Pharmaceutical Holding Company Ltd. stock for Q4 2022, down 100% quarter-over-quarter.
  • 2 funds opened new Biohaven Pharmaceutical Holding Company Ltd. positions in Q4 2022 and 229 closed out, a net change of -227 holders.
  • The largest Biohaven Pharmaceutical Holding Company Ltd. buyer in Q4 2022 was Blue Trust Inc, an estimated $9.87K added.
  • The largest Biohaven Pharmaceutical Holding Company Ltd. seller in Q4 2022 was BlackRock, an estimated $748M sold.

Based on aggregated 13F filings for Q4 2022.